Therapeutics News and Research

RSS
Two drug combinations may provide new treatment option for patients with pancreatic cancers

Two drug combinations may provide new treatment option for patients with pancreatic cancers

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Verastem presents positive results from VS-6063 clinical and preclinical studies at 2013 AACR-NCI-EORTC meeting

Verastem presents positive results from VS-6063 clinical and preclinical studies at 2013 AACR-NCI-EORTC meeting

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

New investigational drug offers potential treatment option for lung cancer

New investigational drug offers potential treatment option for lung cancer

GVI uses Toshiba’s Spot Fluoroscopy to reduce radiation exposure to patients and physicians

GVI uses Toshiba’s Spot Fluoroscopy to reduce radiation exposure to patients and physicians

Cell Therapeutics presents preclinical study results of PIXUVRI at AACR-NCI-EORTC meeting

Cell Therapeutics presents preclinical study results of PIXUVRI at AACR-NCI-EORTC meeting

Scientists find that activating family of small protein could suppress liver malignancies

Scientists find that activating family of small protein could suppress liver malignancies

New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer

New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer

Researchers identify key therapeutic target for cancers driven by KRAS protein

Researchers identify key therapeutic target for cancers driven by KRAS protein

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

SAGE Therapeutics obtains $20M Series B financing from two investors

SAGE Therapeutics obtains $20M Series B financing from two investors

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

Genetics professor turns accidental discovery into a way to study TBI

Genetics professor turns accidental discovery into a way to study TBI

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.